Clinical Trial Update: Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Active Vitamin D with reduced-dose prednisolone for Minimal Change Disease and Nephrotic Syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Change Disease
• Nephrotic Syndrome

Drugs mentioned

• Active Vitamin D
• Prednisolone (Prednisolone)

Snippet

Sponsor: University of Aarhus | Conditions: Minimal Change Disease, Nephrotic Syndrome | Phase 4 | Status: COMPLETED